Adherence to dual antiplatelet therapy with ticagrelor in patients with acute coronary syndromes treated with percutaneous coronary intervention in real life. Results of the REAL-TICA registry-Reference-Cited by-同舟云学术

Adherence to dual antiplatelet therapy with ticagrelor in patients with acute coronary syndromes treated with percutaneous coronary intervention in real life. Results of the REAL-TICA registry

Published:2018-06-07 Issue:4 Volume:4 Page:205-210
ISSN:2055-6837
Container-title:European Heart Journal - Cardiovascular Pharmacotherapy
language:en
Short-container-title:

Author:

Zeymer Uwe¹²,Cully Martin³,Hochadel Mathias²

Affiliation:

1. Klinikum Ludwigshafen, Bremserstrasse 79, Ludwigshafen/Rhein, Germany

2. Institut für Herzinfarktforschung Ludwigshafen, Bremserstrasse 79, Ludwigshafen/Rhein, Germany

3. Munich, Germany

Funder

Astra Zeneca Germany

Institut für Herzinfarkt-forschung Ludwigshafen

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/ehjcvp/article-pdf/4/4/205/25719575/pvy018.pdf

Reference21 articles.

1. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin;Husted;Eur Heart J,2006

2. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009

3. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC);Hamm;Eur Heart J,2011

4. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC);Roffi;Eur Heart J,2016

5. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation;Steg;Eur Heart J,2012

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing Measures of Adherence and Persistence to P2Y12 Inhibitors in Acute Coronary Syndromes;The American Journal of Cardiology;2024-09

2. Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel;Clinical Research in Cardiology;2024-05-13

3. Nonadherence to ticagrelor versus clopidogrel and clinical outcomes in patients with ACS. Results from the CREA-ARIAM registry;Revista Española de Cardiología (English Edition);2024-02

4. Falta de adherencia a ticagrelor frente a clopidogrel y riesgo de eventos en pacientes con SCA. Resultados del registro CREA-ARIAM;Revista Española de Cardiología;2024-02

5. Trajectories of P2Y12 inhibitor adherence in patients with acute coronary syndromes;Pharmacoepidemiology and Drug Safety;2023-09-29